相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Rafting Down the Metastatic Cascade: The Role of Lipid Rafts in Cancer Metastasis, Cell Death, and Clinical Outcomes
Joshua D. Greenlee et al.
CANCER RESEARCH (2021)
uPAR-expressing melanoma exosomes promote angiogenesis by VE-Cadherin, EGFR and uPAR overexpression and rise of ERK1,2 signaling in endothelial cells
Alessio Biagioni et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2021)
Small-Molecule Inhibition of the uPAR uPA Interaction by Conformational Selection
David Xu et al.
CHEMMEDCHEM (2021)
Plasma suPAR may help to distinguish between chronic pancreatitis and pancreatic cancer
Anu Aronen et al.
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2021)
Design and Synthesis of Fragment Derivatives with a Unique Inhibition Mechanism of the uPAR•uPA Interaction
Khuchtumur Bum-Erdene et al.
ACS MEDICINAL CHEMISTRY LETTERS (2021)
Downregulation of uPAR promotes urokinase translocation into the nucleus and epithelial to mesenchymal transition in neuroblastoma
Ekaterina V. Semina et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2020)
uPAR Knockout Results in a Deep Glycolytic and OXPHOS Reprogramming in Melanoma and Colon Carcinoma Cell Lines
Alessio Biagioni et al.
CELLS (2020)
The Contribution of Chemoattractant GPCRs, Formylpeptide Receptors, to Inflammation and Cancer
Weiwei Liang et al.
FRONTIERS IN ENDOCRINOLOGY (2020)
CXCL12/CXCR4 axis in the microenvironment of solid tumors: A critical mediator of metastasis
Keywan Mortezaee
LIFE SCIENCES (2020)
Molecular imaging of the urokinase plasminogen activator receptor: opportunities beyond cancer
V. M. Baart et al.
EJNMMI RESEARCH (2020)
Senolytic CAR T cells reverse senescence-associated pathologies
Corina Amor et al.
NATURE (2020)
New Pieces in the Puzzle of uPAR Role in Cell Migration Mechanisms
Anna Gorrasi et al.
CELLS (2020)
Urokinase receptor deficiency results in EGFR-mediated failure to transmit signals for cell survival and neurite formation in mouse neuroblastoma cells
K. D. Rysenkova et al.
CELLULAR SIGNALLING (2020)
Targeting uPAR by CRISPR/Cas9 System Attenuates Cancer Malignancy and Multidrug Resistance
Kun Wang et al.
FRONTIERS IN ONCOLOGY (2019)
Crystal structure of the unoccupied murine urokinase-type plasminogen activator receptor (uPAR) reveals a tightly packed DII-DIII unit
Min Liu et al.
FEBS LETTERS (2019)
Exploring the MIR143-UPAR Axis for the Inhibition of Human Prostate Cancer Cells In Vitro and In Vivo
Sven Wach et al.
MOLECULAR THERAPY-NUCLEIC ACIDS (2019)
Basing on uPAR-binding fragment to design chimeric antigen receptors triggers antitumor efficacy against uPAR expressing ovarian cancer cells
Liang Wang et al.
BIOMEDICINE & PHARMACOTHERAPY (2019)
Prognostic implications of the co-detection of the urokinase plasminogen activator system and osteopontin in patients with non-small-cell lung cancer undergoing radiotherapy and correlation with gross tumor volume
C. Ostheimer et al.
STRAHLENTHERAPIE UND ONKOLOGIE (2018)
Serum levels of soluble urokinase plasminogen activator receptor (suPAR) predict outcome after resection of colorectal liver metastases
Sven H. Loosen et al.
Oncotarget (2018)
N-Formyl Peptide Receptors Induce Radical Oxygen Production in Fibroblasts Derived From Systemic Sclerosis by Interacting With a Cleaved Form of Urokinase Receptor
Filomena Napolitano et al.
FRONTIERS IN IMMUNOLOGY (2018)
Cellular Senescence: The Sought or the Unwanted?
Yu Sun et al.
TRENDS IN MOLECULAR MEDICINE (2018)
D2A sequence of the urokinase receptor induces cell growth through αvβ3 integrin and EGFR
Gabriele Eden et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2018)
Transforming growth factor-, matrix metalloproteinases, and urokinase-type plasminogen activator interaction in the cancer epithelial to mesenchymal transition
Juan F. Santibanez et al.
DEVELOPMENTAL DYNAMICS (2018)
Epithelial-mesenchymal transition in tumor metastasis
Kay T. Yeung et al.
MOLECULAR ONCOLOGY (2017)
uPA/uPAR system activation drives a glycolytic phenotype in melanoma cells
Anna Laurenzana et al.
INTERNATIONAL JOURNAL OF CANCER (2017)
Inflammatory biomarkers and cancer: CRP and suPAR as markers of incident cancer in patients with serious nonspecific symptoms and signs of cancer
Line Jee Hartmann Rasmussen et al.
INTERNATIONAL JOURNAL OF CANCER (2017)
Regulation of inflammation by members of the formyl-peptide receptor family
Keqiang Chen et al.
JOURNAL OF AUTOIMMUNITY (2017)
Urokinase-type plasminogen activator receptor inhibits apoptosis in triple-negative breast cancer through miR-17/20a suppression of death receptors 4 and 5
Xin Li et al.
ONCOTARGET (2017)
Negative regulation of urokinase receptor activity by a GPI-specific phospholipase C in breast cancer cells
Michiel van Veen et al.
ELIFE (2017)
Urokinase-type plasminogen activator receptor (uPAR) expression enhances invasion and metastasis in RAS mutated tumors
Concetta Di Mauro et al.
SCIENTIFIC REPORTS (2017)
The Prognostic Significance of Soluble Urokinase Plasminogen Activator Receptor in Acute Myeloid Leukemia
Nergiz Erkut et al.
TURKISH JOURNAL OF HEMATOLOGY (2016)
The urokinase receptor-derived cyclic peptide [SRSRY] suppresses neovascularization and intravasation of osteosarcoma and chondrosarcoma cells
Vincenzo Ingangi et al.
ONCOTARGET (2016)
Organization, evolution and functions of the human and mouse Ly6/uPAR family genes
Chelsea L. Loughner et al.
HUMAN GENOMICS (2016)
Reversal of Warburg Effect and Reactivation of Oxidative Phosphorylation by Differential Inhibition of EGFR Signaling Pathways in Non-Small Cell Lung Cancer
Viviana De Rosa et al.
CLINICAL CANCER RESEARCH (2015)
Urokinase receptor and CXCR4 are regulated by common microRNAs in leukaemia cells
Daniela Alfano et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2015)
Inhibition of uPAR-TGFβ crosstalk blocks MSC-dependent EMT in melanoma cells
Anna Laurenzana et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2015)
The interaction of uPAR with VEGFR2 promotes VEGF-induced angiogenesis
Stephanie Herkenne et al.
SCIENCE SIGNALING (2015)
PTEN expression in endothelial cells is down-regulated by uPAR to promote angiogenesis
Matthias Unseld et al.
THROMBOSIS AND HAEMOSTASIS (2015)
The interaction of uPAR with VEGFR2 promotes VEGF-induced angiogenesis
Stephanie Herkenne et al.
SCIENCE SIGNALING (2015)
A Urokinase Receptor-Bim Signaling Axis Emerges during EGFR Inhibitor Resistance in Mutant EGFR Glioblastoma
Jill Wykosky et al.
CANCER RESEARCH (2015)
Differential uPAR recruitment in caveolar-lipid rafts by GM1 and GM3 gangliosides regulates endothelial progenitor cells angiogenesis
Francesca Margheri et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2015)
Urokinase-type plasminogen activator receptor signaling is critical in nasopharyngeal carcinoma cell growth and metastasis
Ying-Na Bao et al.
CELL CYCLE (2014)
FOXM1c Promotes Pancreatic Cancer Epithelial-to-Mesenchymal Transition and Metastasis via Upregulation of Expression of the Urokinase Plasminogen Activator System
Chen Huang et al.
CLINICAL CANCER RESEARCH (2014)
Pericellular proteolysis in cancer
Lisa Sevenich et al.
GENES & DEVELOPMENT (2014)
UPARANT: A Urokinase Receptor-Derived Peptide Inhibitor of VEGF-Driven Angiogenesis with Enhanced Stability and In Vitro and In Vivo Potency
Maria Vincenza Carriero et al.
MOLECULAR CANCER THERAPEUTICS (2014)
The Urokinase Receptor Takes Control of Cell Migration by Recruiting Integrins and FPR1 on the Cell Surface
Anna Gorrasi et al.
PLOS ONE (2014)
Loss of Urokinase Receptor Sensitizes Cells to DNA Damage and Delays DNA Repair
Pavan B. Narayanaswamy et al.
PLOS ONE (2014)
Urokinase receptor promotes ovarian cancer cell dissemination through its 84-95 sequence
Katia Bifulco et al.
ONCOTARGET (2014)
The receptor for urokinase-plasminogen activator (uPAR) controls plasticity of cancer cell movement in mesenchymal and amoeboid migration style
Francesca Margheri et al.
ONCOTARGET (2014)
Network Analyses Reveal Pervasive Functional Regulation Between Proteases in the Human Protease Web
Nikolaus Fortelny et al.
PLOS BIOLOGY (2014)
Urokinase-type plasminogen activator receptor (uPAR) on tumor-associated macrophages is a marker of poor prognosis in colorectal cancer
Martin Illemann et al.
CANCER MEDICINE (2014)
Domain 2 of uPAR regulates single-chain urokinase-mediated angiogenesis through β1-integrin and VEGFR2
Gretchen A. LaRusch et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2013)
The liberated domain I of urokinase plasminogen activator receptor a new tumour marker in small cell lung cancer
Charlotte E. Almasi et al.
APMIS (2013)
Small-molecule inhibition of the uPAR•uPA interaction: Synthesis, biochemical, cellular, in vivo pharmacokinetics and efficacy studies in breast cancer metastasis
Timmy Mani et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2013)
The significance of serum urokinase plasminogen activation receptor (suPAR) in the diagnosis and follow-up of febrile neutropenic patients with hematologic malignancies
Selcuk Kaya et al.
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2013)
Urokinase Receptor Mediates Doxorubicin-Induced Vascular Smooth Muscle Cell Senescence via Proteasomal Degradation of TRF2
Mahshid Hodjat et al.
JOURNAL OF VASCULAR RESEARCH (2013)
Discovery of New Small Molecules Targeting the Vitronectin-Binding Site of the Urokinase Receptor That Block Cancer Cell Invasion
Vincenza Elena Anna Rea et al.
MOLECULAR CANCER THERAPEUTICS (2013)
Targeting of peptide conjugated magnetic nanoparticles to urokinase plasminogen activator receptor (uPAR) expressing cells
Line Hansen et al.
NANOSCALE (2013)
uPAR regulates pericellular proteolysis through a mechanism involving integrins and fMLF-receptors
Nunzia Montuori et al.
THROMBOSIS AND HAEMOSTASIS (2013)
Urokinase Plasminogen Activator Receptor (uPAR) Targeted Nuclear Imaging and Radionuclide Therapy
Dan Li et al.
THERANOSTICS (2013)
Role of Urokinase Receptor in Tumor Progression and Development
Hyangsoon Noh et al.
THERANOSTICS (2013)
A Flexible Multidomain Structure Drives the Function of the Urokinase-type Plasminogen Activator Receptor (uPAR)
Haydyn D. T. Mertens et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Targeting Multiple Conformations Leads to Small Molecule Inhibitors of the uPAR.uPA Protein-Protein Interaction That Block Cancer Cell Invasion
May Khanna et al.
ACS CHEMICAL BIOLOGY (2011)
Endothelial progenitor cell-dependent angiogenesis requires localization of the full-length form of uPAR in caveolae
Francesca Margheri et al.
BLOOD (2011)
Basic and Therapeutic Aspects of Angiogenesis
Michael Potente et al.
CELL (2011)
Downregulation of uPAR inhibits migration, invasion, proliferation, FAK/PI3K/Akt signaling and induces senescence in papillary thyroid carcinoma cells
Theodore S. Nowicki et al.
CELL CYCLE (2011)
The cross-talk between the urokinase receptor and fMLP receptors regulates the activity of the CXCR4 chemokine receptor
Nunzia Montuori et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2011)
The Urokinase-type Plasminogen Activator and the Generation of Inhibitors of Urokinase Activity and Signaling
Maria Vincenza Carriero et al.
CURRENT PHARMACEUTICAL DESIGN (2011)
Four faces of cellular senescence
Francis Rodier et al.
JOURNAL OF CELL BIOLOGY (2011)
Enhanced noscapine delivery using uPAR-targeted optical-MR imaging trackable nanoparticles for prostate cancer therapy
Mohamed O. Abdalla et al.
JOURNAL OF CONTROLLED RELEASE (2011)
Cell Signaling by Urokinase-type Plasminogen Activator Receptor Induces Stem Cell-like Properties in Breast Cancer Cells
Minji Jo et al.
CANCER RESEARCH (2010)
The soluble form of urokinase receptor promotes angiogenesis through its Ser88-Arg-Ser-Arg-Tyr92 chemotactic sequence
K. Bifulco et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2010)
Regulation of cell signalling by uPAR
Harvey W. Smith et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2010)
An Anti-Urokinase Plasminogen Activator Receptor Antibody (ATN-658) Blocks Prostate Cancer Invasion, Migration, Growth, and Experimental Skeletal Metastasis In Vitro and In Vivo
Shafaat A. Rabbani et al.
NEOPLASIA (2010)
Targeting the Urokinase Plasminogen Activator Receptor with Synthetic Self-Assembly Nanoparticles
Ming Wang et al.
BIOCONJUGATE CHEMISTRY (2009)
Receptor-Targeted Nanoparticles for In vivo Imaging of Breast Cancer
Lily Yang et al.
CLINICAL CANCER RESEARCH (2009)
suPAR: The molecular crystal ball
Maria Thuno et al.
DISEASE MARKERS (2009)
Predictive Value of the Differential Expression of the Urokinase Plasminogen Activation Axis in Radical Prostatectomy Patients
Amit Gupta et al.
EUROPEAN UROLOGY (2009)
Multiple activities of a multifaceted receptor: roles of cleaved and soluble uPAR
Nunzia Montuori et al.
FRONTIERS IN BIOSCIENCE-LANDMARK (2009)
Structure-based design of an urokinase-type plasminogen activator receptor-derived peptide inhibiting cell migration and lung metastasis
Maria Vincenza Carriero et al.
MOLECULAR CANCER THERAPEUTICS (2009)
Semiautomatic Landmark-Based Two-Dimensional-Three-Dimensional Image Fusion in Living Mice: Correlation of Near-Infrared Fluorescence Imaging of Cy5.5-Labeled Antibodies with Flat-Panel Volume Computed Tomography
Christian Dullin et al.
MOLECULAR IMAGING (2009)
Imaging of urokinase-type plasminogen activator receptor expression using a 64Cu-labeled linear peptide antagonist by microPET
Zi-Bo Li et al.
CLINICAL CANCER RESEARCH (2008)
An urokinase receptor antagonist that inhibits cell migration by blocking the formyl peptide receptor
Katia Bifulco et al.
FEBS LETTERS (2008)
uPAR-deficient mouse keratinocytes fail to produce EGFR-dependent laminin-5, affecting migration in vivo and in vitro
Silvia D'Alessio et al.
JOURNAL OF CELL SCIENCE (2008)
Crystal structures of two human vitronectin, urokinase and urokinase receptor complexes
Qing Huai et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2008)
Senescence-Associated Secretory Phenotypes Reveal Cell-Nonautonomous Functions of Oncogenic RAS and the p53 Tumor Suppressor
Jean-Philippe Coppe et al.
PLOS BIOLOGY (2008)
uPAR induces epithelial-mesenchymal transition in hypoxic breast cancer cells
Robin D. Lester et al.
JOURNAL OF CELL BIOLOGY (2007)
Intraperitoneal injection of a hairpin RNA - Expressing plasmid targeting urokinase-type plasminogen activator (uPA) receptor and uPA retards angiogenesis and inhibits intracranial tumor growth in nude mice
Christopher S. Gondi et al.
CLINICAL CANCER RESEARCH (2007)
Mapping of the vitronectin-binding site on the urokinase receptor -: Involvement of a coherent receptor interface consisting of residues from both domain I and the flanking interdomain linker region
Henrik Gardsvoll et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Monitoring of chemotherapy successfulness of platina/taxol chemotherapy protocol by using determination of serum urokinase plasminogen activator (uPA) and soluble urokinase plasminogen activator receptor (suPAR) in patients with ovarian carcinoma FIGO II and III stage
Dzenita Ljuca et al.
BOSNIAN JOURNAL OF BASIC MEDICAL SCIENCES (2007)
Association of the circulating levels of the urokinase system of plasminogen activation with the presence of prostate cancer and invasion, progression, and metastasis
Shahrokh F. Shariat et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
A direct link between expression of urokinase plasminogen activator receptor, growth rate and oncogenic transformation in mouse embryonic fibroblasts
R. Mazzieri et al.
ONCOGENE (2007)
VEGF and PlGF promote adult vasculogenesis by enhancing EPC recruitment and vessel formation at the site of tumor neovascularization
Bin Li et al.
FASEB JOURNAL (2006)
A region in urokinase plasminogen receptor domain III controlling a functional association with α5β1 integrin and tumor growth
Pratima Chaurasia et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
The urokinase receptor: a ligand or a receptor? Story of a sociable molecule
P. Ragno
CELLULAR AND MOLECULAR LIFE SCIENCES (2006)
Structure of human urokinase plasminogen activator in complex with its receptor
Q Huai et al.
SCIENCE (2006)
Domain 2 of the urokinase receptor contains an integrin-interacting epitope with intrinsic signaling activity - Generation of a new integrin inhibitor
B Degryse et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Urokinase-induced signaling in human vascular smooth muscle cells is mediated by PDGFR-β
J Kiyan et al.
EMBO JOURNAL (2005)
Preoperative plasma soluble urokinase plasminogen activator receptor as a prognostic marker in rectal cancer patients.: An EORTC-receptor and Biomarker Group collaboration
R Riisbro et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS (2005)
Transcriptional and posttranscriptional regulation of the plasminogen activator system
Y Nagamine et al.
THROMBOSIS AND HAEMOSTASIS (2005)
Real-time quantitative PCR determination of urokinase-type plasminogen activator receptor (uPAR) expression of isolated micrometastatic cells from bone marrow of breast cancer patients
JY Pierga et al.
INTERNATIONAL JOURNAL OF CANCER (2005)
Involvement of the urokinase-type plasminogen activator receptor in hematopoietic stem cell mobilization
C Selleri et al.
BLOOD (2005)
Soluble and cleaved forms of the urokinase-receptor: degradation products or active molecules?
N Montuori et al.
THROMBOSIS AND HAEMOSTASIS (2005)
Metabolism of tumour-derived urokinase receptor and receptor fragments in cancer patients and xenografted mice
CFM Sier et al.
THROMBOSIS AND HAEMOSTASIS (2004)
Urokinase induces basophil chemotaxis through a urokinase receptor or epitope that is an endogenous ligand for formyl peptide receptor-like 1 and -like 2
A de Paulis et al.
JOURNAL OF IMMUNOLOGY (2004)
Dimerization controls the lipid raft partitioning of uPAR/CD87 and regulates its biological functions
O Cunningham et al.
EMBO JOURNAL (2003)
Expression of antisense uPAR and antisense uPA from a bicistronic adenoviral construct inhibits glioma cell invasion, tumor growth, and angiogenesis
CS Gondi et al.
ONCOGENE (2003)
The cleavage of the urokinase receptor regulates its multiple functions
N Montuori et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
The fibrinolytic receptor for urokinase activates the G protein-coupled chemotactic receptor FPRL1/LXA4R
M Resnati et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Peptide-derived antagonists of the urokinase receptor.: Affinity maturation by combinatorial chemistry, identification of functional epitopes, and inhibitory effect on cancer cell intravasation
M Ploug et al.
BIOCHEMISTRY (2001)
Urokinase-receptor/integrin complexes are functionally involved in adhesion and progression of human breast cancer in vivo
G van der Pluijm et al.
AMERICAN JOURNAL OF PATHOLOGY (2001)
Identification of a urokinase receptor-integrin interaction site - Promiscuous regulator of integrin function
DI Simon et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
分享论文
